Sabine Tews | General Manager, Gilead Sciences BeNeLux
Sabine Tews, PhD, is a a distinguished leader in the life sciences realm, currently leading as General Manager for the Benelux at Gilead Sciences. Her impressive career reflects a commitment to advancing healthcare through innovative solutions and strategic leadership.
At Gilead Sciences, Dr. Tews manages regional operations, spearheading initiatives that ensure the delivery of exceptional healthcare products. Her strategic insights and dedication to improving patient welfare distinguish her as a key leader in the industry.
Prior to her current role, Dr. Tews held a range of senior leadership positions across the biopharmaceutical sector in multiple countries, including Germany, the United Kingdom, and the Netherlands. Her multidisciplinary and broad international expertise spans research and development, as well as commercial strategy and execution across the EMEA region, underscoring her versatility and influence in both scientific and business domains.
In addition to her corporate responsibilities, Dr. Tews actively contributes to the Vereniging Innovatieve Geneesmiddelen (VIG) as a board member. She advocates for greater accessibility to groundbreaking healthcare treatments, reflecting her unwavering dedication to patient-centered healthcare.
Holding a PhD in Molecular Biology, Dr. Tews brings a strong scientific foundation and analytical acumen to her endeavors. Beyond her professional contributions, she is a passionate supporter of health equity and a vocal proponent of women's leadership in life sciences, inspiring future leaders to drive meaningful developments in healthcare.
Gilead Sciences BENELUX is part of Gilead Sciences Inc., a U.S.-based global biopharmaceutical company headquartered in Foster City, California. For over three decades, Gilead has pursued and achieved medical breakthroughs with the goal of creating a healthier world for all people.The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. Gilead operates in more than 35 countries worldwide.In the BENELUX region, around 1,000 colleagues work from offices in Amsterdam and Brussels, and from our Kite CAR T manufacturing site near Amsterdam. Together, we contribute to Gilead’s mission of discovering, developing, and delivering innovative therapies for people with life-threatening diseases.
Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | |
|
© Copyright 2020 by Hyphen Projects